Development of infectious recombinant BK virus

Virus Research

Volumn 161, Issue 2, 2011, Pages 150-161

  Husseiny, Mohamed I ^a   Lacey, Simon F ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Agnoprotein; BK virus; Polyomavirus; Reporter virus; VP2

Indexed keywords

AGNOPROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; MESSENGER RNA; PROTEIN VP1; PROTEIN VP2; PROTEIN VP3; VIRUS T ANTIGEN;

ANIMAL CELL; ARTICLE; BK VIRUS; GENE CONSTRUCT; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TRANSCRIPTION INITIATION; VIRUS GENOME; VIRUS VIABILITY;

ANIMALS; BK VIRUS; CAPSID PROTEINS; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; GENE EXPRESSION REGULATION, VIRAL; GENETIC ENGINEERING; GENOME, VIRAL; HUMANS; POLYOMAVIRUS INFECTIONS; PROMOTER REGIONS, GENETIC; VIRION; VIRUS REPLICATION;

BK POLYOMAVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE; POLYOMAVIRUS;

EID: 84860407578     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.07.017     Document Type: Article

References (34)

1. Abend J.R., Jiang M., Imperiale M.J. BK virus and human cancer: innocent until proven guilty. Semin. Cancer Biol. 2009, 19(4):252-260.
2. Bernhoff E., Gutteberg T.J., Sandvik K., Hirsch H.H., Rinaldo C.H. Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression. Am. J. Transplant 2008, 8(7):1413-1422.
3. Caputo A., Barbanti-Brodano G., Wang E., Ricciardi R.P. Transactivation of BKV and SV40 early promoters by BKV and SV40 T- antigens. Virology 1986, 152(2):459-465.
4. Caputo A., Sodroski J.G., Haseltine W.A. Constitutive expression of HIV-1 tat protein in human Jurkat T cells using a BK virus vector. J. Acquir. Immune. Defic. Syndr. 1990, 3(4):372-379.
5. Comoli P., Binggeli S., Ginevri F., Hirsch H.H. Polyomavirus-associated nephropathy: update on BK virus-specific immunity. Transpl. Infect. Dis. 2006, 8(2):86-94.
6. de Felipe P. Skipping the co-expression problem: the new 2A CHYSEL technology. Genetic Vaccines Ther. 2004, 2(1):13.
7. Dugan A.S., Gasparovic M.L., Tsomaia N., Mierke D.F., O'Hara B.A., Manley K., Atwood W.J. Identification of amino acid residues in BK virus VP1 that are critical for viability and growth. J. Virol. 2007, 81(21):11798-11808.
8. Egli A., Infanti L., Dumoulin A., Buser A., Samaridis J., Stebler C., Gosert R., Hirsch H.H. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J. Infect. Dis. 2009, 199(6):837-846.
9. Gasparovic M.L., Gee G.V., Atwood W.J. JC virus minor capsid proteins Vp2 and Vp3 are essential for virus propagation. J. Virol. 2006, 80(21):10858-10861.
10. Gluzman Y. SV40-transformed simian cells support the replication of early SV40 mutants. Cell 1981, 23(1):175-182.
11. Gosert R., Rinaldo C.H., Funk G.A., Egli A., Ramos E., Drachenberg C.B., Hirsch H.H. Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology. J. Exp. Med. 2008, 205(4):841-852.
12. Grinde B., Gayorfar M., Rinaldo C.H. Impact of a polyomavirus (BKV) infection on mRNA expression in human endothelial cells. Virus Res. 2007, 123(1):86-94.
13. Hanssen Rinaldo C., Hansen H., Traavik T. Human endothelial cells allow passage of an archetypal BK virus (BKV) strain-a tool for cultivation and functional studies of natural BKV strains. Arch. Virol. 2005, 150(7):1449-1458.
14. Husseiny M.I., Anastasi B., Singer J., Lacey S.F. A Comparative Study of Merkel cell, BK and JC polyomavirus infections in renal transplant recipients and healthy subjects. J. Clin. Virol. 2010.
15. Kadambi P.V., Josephson M.A., Williams J., Corey L., Jerome K.R., Meehan S.M., Limaye A.P. Treatment of Refractory BK Virus-Associated Nephropathy With Cidofovir. Am. J. Transplant. 2003, 3(2):186-191.
16. Krymskaya L., Sharma M.C., Martinez J., Haq W., Huang E.C., Limaye A.P., Diamond D.J., Lacey S.F. Cross-Reactivity of T Lymphocytes Recognizing a Human Cytotoxic T-Lymphocyte Epitope within BK and JC Virus VP1 Polypeptides. J. Virol. 2005, 79(17):11170-11178.
17. Kuypers D.R., Bammens B., Claes K., Evenepoel P., Lerut E., Vanrenterghem Y. A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients. J. Antimicrob. Chemother. 2009, 63(2):417-419.
18. Kuypers D.R., Vandooren A.K., Lerut E., Evenepoel P., Claes K., Snoeck R., Naesens L., Vanrenterghem Y. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am. J. Transplant. 2005, 5(8):1997-2004.
19. Milanesi G., Barbanti-Brodano G., Negrini M., Lee D., Corallini A., Caputo A., Grossi M.P., Ricciardi R.P. BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli. Mol. Cell. Biol. 1984, 4(8):1551-1560.
20. Moens U., Van Ghelue M., Johansen B., Seternes O.M. Concerted expression of BK virus large T- and small t-antigens strongly enhances oestrogen receptor-mediated transcription. J. Gen. Virol. 1999, 80(Pt 3):585-594.
21. Myhre M.R., Olsen G.H., Gosert R., Hirsch H.H., Rinaldo C.H. Clinical polyomavirus BK variants with agnogene deletion are non-functional but rescued by trans-complementation. Virology 2010, 398(1):12-20.
22. Nakanishi A., Chapellier B., Maekawa N., Hiramoto M., Kuge T., Takahashi R.U., Handa H., Imai T. SV40 vectors carrying minimal sequence of viral origin with exchangeable capsids. Virology 2008, 379(1):110-117.
23. Negrini M., Sabbioni S., Arthur R.R., Castagnoli A., Barbanti-Brodano G. Prevalence of the archetypal regulatory region and sequence polymorphisms in nonpassaged BK virus variants. J. Virol. 1991, 65(9):5092-5095.
24. Olsen G.H., Hirsch H.H., Rinaldo C.H. Functional analysis of polyomavirus BK non-coding control region quasispecies from kidney transplant recipients. J. Med. Virol. 2009, 81(11):1959-1967.
25. Pho M.T., Ashok A., Atwood W.J. JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis. J. Virol. 2000, 74(5):2288-2292.
26. Pipas J.M. Common and unique features of T antigens encoded by the polyomavirus group. J. Virol. 1992, 66(7):3979-3985.
27. Randhawa P., Vats A., Shapiro R. Monitoring for polyomavirus BK And JC in urine: comparison of quantitative polymerase chain reaction with urine cytology. Transplantation 2005, 79(8):984-986.
28. Rinaldo C.H., Traavik T., Hey A. The agnogene of the human polyomavirus BK is expressed. J. Virol. 1998, 72(7):6233-6236.
29. Ryan M.D., King A.M., Thomas G.P. Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. J. Gen. Virol. 1991, 2(Pt 11):2727-2732.
30. ter Schegget J., Sol C.J., Baan E.W., van der N.J., van Ormondt H. Naturally occurring BK virus variants (JL and Dik) with deletions in the putative early enhancer-promoter sequences. J. Virol. 1985, 53(1):302-305.
31. Touze A., Bousarghin L., Ster C., Combita A.L., Roingeard P., Coursaget P. Gene transfer using human polyomavirus BK virus-like particles expressed in insect cells. J. Gen. Virol. 2001, 82(Pt 12):3005-3009.
32. Yang R.C., Wu R. BK virus DNA: complete nucleotide sequence of a human tumor virus. Science 1979, 206(4417):456-462.
33. Zaragoza C., Li R.M., Fahle G.A., Fischer S.H., Raffeld M., Lewis A.M., Kopp J.B. Squirrel monkeys support replication of BK virus more efficiently than simian virus 40: an animal model for human BK virus infection. J. Virol. 2005, 79(2):1320-1326.
34. Zhong S., Zheng H.Y., Suzuki M., Chen Q., Ikegaya H., Aoki N., Usuku S., Kobayashi N., Nukuzuma S., Yasuda Y., Kuniyoshi N., Yogo Y., Kitamura T. Age-related urinary excretion of BK polyomavirus by nonimmunocompromised individuals. J. Clin. Microbiol. 2007, 45(1):193-198.